UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:OXR1-EIF3E |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: OXR1-EIF3E | FusionPDB ID: 62036 | FusionGDB2.0 ID: 62036 | Hgene | Tgene | Gene symbol | OXR1 | EIF3E | Gene ID | 55074 | 3646 |
Gene name | oxidation resistance 1 | eukaryotic translation initiation factor 3 subunit E | |
Synonyms | CHEGDD|Nbla00307|TLDC3 | EIF3-P48|EIF3S6|INT6|eIF3-p46 | |
Cytomap | 8q23.1 | 8q23.1 | |
Type of gene | protein-coding | protein-coding | |
Description | oxidation resistance protein 1TBC/LysM-associated domain containing 3putative protein product of Nbla00307 | eukaryotic translation initiation factor 3 subunit EeIF-3 p48eukaryotic translation initiation factor 3 subunit 6eukaryotic translation initiation factor 3 subunit E isoform 2 transcripteukaryotic translation initiation factor 3, subunit 6 (48kD)euka | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P60228 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000312046, ENST00000442977, ENST00000445937, ENST00000497705, ENST00000517566, ENST00000531443, ENST00000452423, ENST00000297447, ENST00000449762, ENST00000521592, ENST00000521963, | ENST00000519517, ENST00000220849, ENST00000519030, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 23 X 21 X 9=4347 | 21 X 12 X 10=2520 |
# samples | 25 | 21 | |
** MAII score | log2(25/4347*10)=-4.120020095616 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/2520*10)=-3.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: OXR1 [Title/Abstract] AND EIF3E [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | OXR1(107705105)-EIF3E(109214152), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | OXR1-EIF3E seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. OXR1-EIF3E seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. OXR1-EIF3E seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. OXR1-EIF3E seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. OXR1-EIF3E seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. OXR1-EIF3E seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. OXR1-EIF3E seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | EIF3E | GO:0006413 | translational initiation | 17581632 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-A4QI-01A | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000445937 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 1117 | 936 | 219 | 974 | 251 |
ENST00000531443 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 994 | 813 | 96 | 851 | 251 |
ENST00000517566 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 994 | 813 | 96 | 851 | 251 |
ENST00000442977 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 958 | 777 | 81 | 815 | 244 |
ENST00000312046 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 968 | 787 | 133 | 825 | 230 |
ENST00000497705 | OXR1 | chr8 | 107705105 | + | ENST00000220849 | EIF3E | chr8 | 109214152 | - | 694 | 513 | 39 | 551 | 170 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000445937 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.001669398 | 0.99833065 |
ENST00000531443 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.001395127 | 0.99860483 |
ENST00000517566 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.001395127 | 0.99860483 |
ENST00000442977 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.004087247 | 0.99591273 |
ENST00000312046 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.003631496 | 0.9963685 |
ENST00000497705 | ENST00000220849 | OXR1 | chr8 | 107705105 | + | EIF3E | chr8 | 109214152 | - | 0.00918531 | 0.99081475 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >62036_62036_1_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000312046_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=230AA_BP= MDYLTTFTEKSGRLLRGTANRLLGFGGGGEARQVRFEDYLREPAQGDLGCGSPPHRPPAPSSPEGPDTGQKKTLDKKDGRRMSFQKPKGT IEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLSPVSPLSPTSSEAEFDKTTNPDVHPTEATPS -------------------------------------------------------------- >62036_62036_2_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000442977_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=244AA_BP= MPACTEMTKDKNSPGLKKKSQSVDINAPGFNPLAGAGKQTPQASKPPAPKTPIIEEEQNNAANTQKHPSRRSELKRFYTIDTGQKKTLDK KDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLSPVSPLSPTSSEAEFDK -------------------------------------------------------------- >62036_62036_3_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000445937_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=251AA_BP= MFWNREKTPQQVAAMSVSNLSWLKKKSQSVDINAPGFNPLAGAGKQTPQASKPPAPKTPIIEEEQNNAANTQKHPSRRSELKRFYTIDTG QKKTLDKKDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLSPVSPLSPTS -------------------------------------------------------------- >62036_62036_4_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000497705_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=170AA_BP= MFCQRKDTGQKKTLDKKDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLS -------------------------------------------------------------- >62036_62036_5_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000517566_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=251AA_BP= MFWNREKTPQQVAAMSVSNLSWLKKKSQSVDINAPGFNPLAGAGKQTPQASKPPAPKTPIIEEEQNNAANTQKHPSRRSELKRFYTIDTG QKKTLDKKDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLSPVSPLSPTS -------------------------------------------------------------- >62036_62036_6_OXR1-EIF3E_OXR1_chr8_107705105_ENST00000531443_EIF3E_chr8_109214152_ENST00000220849_length(amino acids)=251AA_BP= MFWNREKTPQQVAAMSVSNLSWLKKKSQSVDINAPGFNPLAGAGKQTPQASKPPAPKTPIIEEEQNNAANTQKHPSRRSELKRFYTIDTG QKKTLDKKDGRRMSFQKPKGTIEYTVESRDSLNSIALKFDTTPNELVQLNKLFSRAVVTGQVLYVPDPEYVSSVESSPSLSPVSPLSPTS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:107705105/chr8:109214152) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | EIF3E |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). Required for nonsense-mediated mRNA decay (NMD); may act in conjunction with UPF2 to divert mRNAs from translation to the NMD pathway (PubMed:17468741). May interact with MCM7 and EPAS1 and regulate the proteasome-mediated degradation of these proteins (PubMed:17310990, PubMed:17324924). {ECO:0000255|HAMAP-Rule:MF_03004, ECO:0000269|PubMed:17310990, ECO:0000269|PubMed:17324924, ECO:0000269|PubMed:17468741, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000312046 | + | 5 | 14 | 99_142 | 218.0 | 840.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000442977 | + | 6 | 16 | 99_142 | 226.0 | 875.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000445937 | + | 7 | 16 | 99_142 | 225.0 | 847.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000497705 | + | 5 | 7 | 99_142 | 158.0 | 504.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000517566 | + | 6 | 16 | 99_142 | 225.0 | 874.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000531443 | + | 6 | 15 | 99_142 | 225.0 | 847.0 | Domain | LysM |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000297447 | + | 1 | 7 | 208_275 | 0 | 244.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000297447 | + | 1 | 7 | 713_874 | 0 | 244.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000297447 | + | 1 | 7 | 99_142 | 0 | 244.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000312046 | + | 5 | 14 | 208_275 | 218.0 | 840.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000312046 | + | 5 | 14 | 713_874 | 218.0 | 840.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000442977 | + | 6 | 16 | 208_275 | 226.0 | 875.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000442977 | + | 6 | 16 | 713_874 | 226.0 | 875.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000445937 | + | 7 | 16 | 208_275 | 225.0 | 847.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000445937 | + | 7 | 16 | 713_874 | 225.0 | 847.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000449762 | + | 1 | 6 | 208_275 | 0 | 217.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000449762 | + | 1 | 6 | 713_874 | 0 | 217.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000449762 | + | 1 | 6 | 99_142 | 0 | 217.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000452423 | + | 6 | 14 | 208_275 | 0 | 295.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000452423 | + | 6 | 14 | 713_874 | 0 | 295.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000452423 | + | 6 | 14 | 99_142 | 0 | 295.0 | Domain | LysM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000497705 | + | 5 | 7 | 208_275 | 158.0 | 504.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000497705 | + | 5 | 7 | 713_874 | 158.0 | 504.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000517566 | + | 6 | 16 | 208_275 | 225.0 | 874.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000517566 | + | 6 | 16 | 713_874 | 225.0 | 874.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000531443 | + | 6 | 15 | 208_275 | 225.0 | 847.0 | Domain | Note=GRAM |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000531443 | + | 6 | 15 | 713_874 | 225.0 | 847.0 | Domain | TLDc |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000297447 | + | 1 | 7 | 551_578 | 0 | 244.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000312046 | + | 5 | 14 | 551_578 | 218.0 | 840.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000442977 | + | 6 | 16 | 551_578 | 226.0 | 875.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000445937 | + | 7 | 16 | 551_578 | 225.0 | 847.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000449762 | + | 1 | 6 | 551_578 | 0 | 217.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000452423 | + | 6 | 14 | 551_578 | 0 | 295.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000497705 | + | 5 | 7 | 551_578 | 158.0 | 504.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000517566 | + | 6 | 16 | 551_578 | 225.0 | 874.0 | Region | Note=Mediates oxidative antimutator activity |
Hgene | OXR1 | chr8:107705105 | chr8:109214152 | ENST00000531443 | + | 6 | 15 | 551_578 | 225.0 | 847.0 | Region | Note=Mediates oxidative antimutator activity |
Tgene | EIF3E | chr8:107705105 | chr8:109214152 | ENST00000220849 | 11 | 13 | 221_398 | 433.0 | 446.0 | Domain | PCI |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
OXR1 | |
EIF3E |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to OXR1-EIF3E |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to OXR1-EIF3E |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |